Clinical Trials Directory

Trials / Completed

CompletedNCT06499675

Prevalence of Steatosis and Steatohepatitis in Patients Undergoing Bariatric Surgery; a Biopsy-based Study

Status
Completed
Phase
Study type
Observational
Enrollment
272 (actual)
Sponsor
Egyptian Liver Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To study the prevalence of steatosis, steatohepatitis, and their associated risk factors in obese patients undergoing bariatric surgery.

Detailed description

A prospective single-center biopsy-based study was conducted on 162 sleeve gastrectomy patients. Patient characteristics, including age, sex, diabetes mellitus (DM) status, body mass index (BMI), liver function tests, lipogram, homeostatic model assessment of insulin resistance (HOMA-IR), and steatosis were also assessed using controlled attenuation parameter (CAP), and intra operative liver biopsies were obtained. , The presence of steatosis and steatohepatitis were histologically assessed by two expert pathologists.

Conditions

Interventions

TypeNameDescription
PROCEDUREsleeve gastrectomysleeve gastrectomy / bariatric surgery
PROCEDURELiver Biopsyintraoperative liver biopsy

Timeline

Start date
2019-05-01
Primary completion
2023-12-31
Completion
2024-05-31
First posted
2024-07-12
Last updated
2024-07-12

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06499675. Inclusion in this directory is not an endorsement.